Dr. Clarke brings more than 15 years of cell and gene related experience to Discovery. He is the acting chair for the International Society for Cell and Gene Therapies (ISCT) Process and Product Development Committee – a global industry leadership forum directed toward translating research and process development from bench to clinic through education and guidance. Prior to joining Discovery, he served as Global Head of Cell Therapy for HemaCare, a Charles River company. During his tenure there, he developed and led the company’s global cell therapy corporate strategy, provided scientific and technical expertise both operationally and commercially, and spearheaded innovation across the organization.